Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

Laboratory Report

Patient
Name: Smith, , Timothy,
DOB: 10-SEP-1941 (Age: 84)
Gender: male
Address:
9 Jeffrey orchard
NW1 North Joshuaville (United Kingdom)
ID: 8029-862360-6 (ECI)
Report
Date: 17-DEC-2018
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Evelina Children's Hospital
SE1 7 London (United Kingdom)
Specimen
Collected: 17-DEC-2018

Chemistry

Test 17-DEC-2018 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.5 4.5 - 6.4 %
Glucose [Mass/volume] in Blood 161.7 H 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 18.5 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 0.7 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.6 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 140.2 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.9 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 106.8 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 27.5 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 257.5 H 0 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 326.1 H 0 - 199 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 161.7 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 30.6 L 40 - 100 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 3.6 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows significant dyslipidemia (elevated total cholesterol, LDL, triglycerides, and low HDL), and mildly elevated fasting glucose, suggesting increased cardiovascular and metabolic risk. Renal function and electrolytes are within normal limits, and there is no evidence of microalbuminuria. Continued monitoring and management of lipid and glucose levels are recommended.